-
Novavax, Inc. (NVAX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript
12 Jun 2025 01:49 GMT
Novavax, Inc. (NASDAQ:NVAX) Goldman Sachs …
John Charles Jacobs - President, CEO & Director
Ruxandra Draghia-Akli … 'm John Jacobs, CEO of Novavax, and I'm joined … are more new to the Novavax story in the last few …
-
FDA approves Novavax COVID shot
20 May 2025 17:57 GMT
… higher risk. The Novavax decision suggests the Trump … advance of that meeting.
Novavax chief executive John C. Jacobs welcomed … and other Trump officials.
Novavax originally showed its vaccine … confidential agency matters.
Novavax later announced the FDA …
-
FDA Approves Novavax’s COVID-19 Vaccine BLA
20 May 2025 15:37 GMT
… C. Jacobs, President and Chief Executive Officer, Novavax. “Market research and U … and license agreement between Novavax and Sanofi signed in … has layers of value for Novavax. Sanofi is leading on … for severe COVID-19. Novavax is working closely with Sanofi …
-
US FDA approves Novavax’s BLA for Covid-19 vaccine, Nuvaxovid
20 May 2025 10:09 GMT
… C. Jacobs, president and chief executive officer, Novavax. "Market research … and license agreement between Novavax and Sanofi signed in … causes Covid-19. With Novavax's unique recombinant … the basis of Novavax's expanding pipeline.
Novavax, Inc. …
-
FDA Grants Novavax COVID-19 Vaccine Full Approval for High-Risk Groups
20 May 2025 21:15 GMT
… John C Jacobs, Novavax president and CEO said in the statement … , according to Novavax.1
NVX-CoV2373 utilizes Novavax's … 1056/NEJMoa2116185
3. Novavax initiates pediatric expansion for … #47;fda-authorizes-updated-novavax-covid-19-vaccine-better- …
-
FDA Approves Novavax COVID Vaccine, But With Restrictions
20 May 2025 12:46 GMT
… Drug Administration (FDA), Novavax has announced approval of … population than intended.
The Novavax COVID-19 vaccine (Nuvaxovid™), … delayed the decision, despite Novavax feeling the vaccine was … a statement, John Jacobs, Novavax’s CEO, said, “Market research …
-
Novavax’s COVID vaccine gets FDA approval, but with limits
19 May 2025 18:23 GMT
… COVID-19 vaccination seasonally,” Novavax CEO John Jacobs said in a …
The FDA is requiring Novavax conduct a new placebo-controlled … -controlled trials before approval.
Novavax’s commitments won’t restrict … of $175 million from Novavax’s partner Sanofi, which …
-
Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment
19 May 2025 15:29 GMT
… sought additional data.
Related: Novavax Wins Limited FDA Nod For … Groups Amid Safety Scrutiny
Novavax CEO John C. Jacobs called … and high-risk groups.
Novavax plans to begin commercial … by the FDA.
Financially, Novavax reaffirmed its 2025 forecast …
-
U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine
19 May 2025 11:30 GMT
… John C. Jacobs, President and Chief Executive Officer, Novavax. "Market research and … and pericarditis following administration of Novavax COVID-19 Vaccine, Adjuvanted. … the basis of Novavax's expanding pipeline.
About Novavax
Novavax, Inc. (Nasdaq …
-
After FDA holdup, Novavax secures full approval for protein-based COVID vaccine
19 May 2025 22:58 GMT
… same population restrictions as Novavax’s prophylactic, the company … vaccination seasonally,” John Jacobs, Novavax’s CEO, said in a statement. … journey to approval for Novavax, which expected its shot … $500 million upfront—on Novavax’s vaccine platform last …